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Abbreviation 
ACM = all-cause mortality 
AF = atrial fibrillation 
CVM = cardiovascular mortality 
Fitness = cardiorespiratory fitness 
HRs = hazard ratios 
METs = metabolic equivalents 
PA = physical activity 

















To the Editor:  
The debate exists on whether the dose-response relation between physical activity (PA) 
and mortality benefits is in fact curvilinear, U-shaped, or J shaped curve.1,2 Cardiorespiratory 
fitness (fitness), highly reflective of habitual PA, is a strong protective of varied adverse health 
outcomes including cardiovascular disease (CVD)3,4 and is also associated with lower health 
care costs.5 It has been suggested that high fitness levels may be at least as important as lower 
body mass index in CVD prevention.6 However, there is still uncertainty whether an upper limit 
or plateau exists for the cardioprotective effects of increased levels of fitness.4 In this study, we 
aimed to evaluate the dose-response relationship between fitness and cardiovascular outcomes 
and to identify the upper threshold of benefit due to increasing levels of fitness. 
Patients and Methods. 
The study included 2,368 subjects (aged 42-61 years) from an ongoing population-based 
prospective cohort study in eastern Finland (the Kuopio Ischemic Heart Disease Study). Fitness 
was directly measured via peak oxygen uptake (VO2peak, ml/kg/min) during an electrically 
braked cycle ergometer exercise test to volitional fatigue/exhaustion. VO2peak was defined as 
the highest attained value for oxygen consumption and/or a plateau in oxygen uptake at 
maximal exercise, and expressed as metabolic equivalents (METs; 1 MET = 3.5 mL 
O2/kg/min). Levels of fitness were categorized according to peak metabolic equivalents (<5 
[the lowest], 5-6.9, 7-8.9, 9-10.9, 11-13, and >13 METs [the highest]) attained. The outcomes 
were defined as all-cause mortality (ACM), cardiovascular mortality (CVM), sudden cardiac 
death (SCD) and atrial fibrillation (AF) ascertained from hospital notes and discharge lists, 
death certificates, informant interviews, health practitioner questionnaires, electrocardiograms, 
medico-legal reports and vital statistics offices from study enrollment until the end of 2014. To 
characterize shapes or the dose-response nature of the associations, hazard ratios (HRs) were 
calculated within the categories of baseline peak METs and plotted against mean peak 
metabolic equivalent within each category using floating absolute risks. 
Results. 
During a median follow-up of 25 years (interquartile ranges: 18-27 years), 1,116 ACM, 
512 CVM, 221 SCD, and 440 AF occurred, respectively. The figure 1 shows the dose-response 
nature of the relationships between levels of peak METs and cardiovascular outcomes. After 
adjusting for age, body mass index, smoking, systolic blood pressure, total cholesterol, glucose, 
C-reactive protein, and PA level, the risk of ACM decreased gradually with increasing peak 
METs in a continuous dose-response manner across the whole range of peak METs. For both 
CVM and SCD, the risks decreased with increasing peak METs up to 9.9 METs, beyond which 
there were no further decreases in risks. However, for SCD, there was no significant benefit at 
peak METs > 13 METs. The relationship between peak METs and AF appeared U or reverse J 
shaped, and the upper threshold of risk reduction occurred at 9.9 METs, with no significant 
benefit at > 13 METs.  
Discussion. 
Our novel findings indicate that there is no upper limit of ACM benefit associated with 
increased levels of fitness. The upper threshold of CVM, SCD, and AF benefits occurred at 9.9 
METs, suggesting that this fitness level confers multiple cardioprotective effects in middle-
aged men aged 42 to 61 years. We observed that higher fitness, measured directly using the 
gold-standard method of expired gas analysis during cardiopulmonary exercise testing, was 
associated with decreased ACM in a linear dose-response manner with no evidence of a 
threshold effect; a finding which is in line with a previous report of no upper threshold for 
ACM benefit associated with increased levels of indirectly estimated fitness.7  Therefore, it 
should be emphasized that higher fitness is largely associated with reduction in the risk of ACM 
(“higher is better”). The dose-response relation between PA level and CVM benefits is 
consistent with a curvilinear or a reverse J shape according to recent meta-analysis.1,2 Our 
results appear similar to that of previous studies and we observed the risk reduction of CVM 
and SCD with increased fitness occurred at a peak of about 10 METs, largely consistent with 
an L shaped curve. However, there was neither additional risk reduction nor evidence of harm 
observed beyond this point. Though at fitness levels > 13 METs, there was still significant 
benefit for CVM, there was no benefit for SCD. Therefore, it should be emphasized that CVM 
and SCD benefits were attenuated at the highest level of fitness (“higher is not always better”). 
A meta-analysis and recent state-of-the-art review of AF indicated an inverse association 
between fitness and the risk of AF.8,9 However, it is unclear whether higher fitness results in 
the greater benefit or little is known about the point of fitness where the benefits diminish or 
there is a decrease in the risk of AF. We observed a reverse J shaped relationship between fitness 
and AF, and the upper threshold of risk reduction benefit occurred at 9.9 METs, with no 
additional risk reduction observed beyond this point. These results are potentially consistent 
with previous studies, which demonstrate that extreme levels of PA increase the risk of AF.10 
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Figure 1. The hazard ratios of all-cause mortality, cardiovascular mortality, sudden cardiac 
death, and atrial fibrillation according to increased cardiorespiratory fitness levels after 
adjusted for age, body mass index, smoking, systolic blood pressure, total cholesterol, glucose, 
C-reactive protein, and physical activity, 
 
 
 
  
  
 
